MPCG
CVS icon

Matrix Private Capital Group’s CVS Health CVS Stock Holding History

Matrix Private Capital Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$280K Sell
3,897
-83
-2% -$6.39K 0.13% 80
2025
Q4 		$316K Buy
3,980
+190
+5% +$15K 0.16% 73
2025
Q3 		$286K Sell
3,790
-746
-16% -$51.1K 0.15% 73
2025
Q2 		$313K Sell
4,536
-2,332
-34% -$153K 0.18% 70
2025
Q1 		$465K Sell
6,868
-354
-5% -$21.2K 0.28% 59
2024
Q4 		$324K Sell
7,222
-4,518
-38% -$253K 0.18% 77
2024
Q3 		$738K Sell
11,740
-1,373
-10% -$80.1K 0.43% 44
2024
Q2 		$774K Sell
13,113
-108
-0.8% -$6.76K 0.49% 37
2024
Q1 		$1.05M Sell
13,221
-294
-2% -$22.5K 0.71% 30
2023
Q4 		$1.07M Sell
13,515
-100
-0.7% -$7.12K 0.81% 28
2023
Q3 		$951K Sell
13,615
-6
-0% -$425 0.71% 31
2023
Q2 		$942K Sell
13,621
-106
-0.8% -$7.54K 0.69% 34
2023
Q1 		$1.02M Sell
13,727
-596
-4% -$50K 0.71% 34
2022
Q4 		$1.33M Sell
14,323
-589
-4% -$56.8K 0.87% 27
2022
Q3 		$1.42M Sell
14,912
-817
-5% -$80.9K 0.96% 24
2022
Q2 		$1.46M Sell
15,729
-1,545
-9% -$151K 0.83% 26
2022
Q1 		$1.75M Sell
17,274
-2,062
-11% -$217K 0.85% 26
2021
Q4 		$2M Sell
19,336
-917
-5% -$84.7K 0.94% 25
2021
Q3 		$1.72M Buy
20,253
+291
+1% +$24.4K 0.9% 23
2021
Q2 		$1.67M Buy
19,962
+1
+0% +$82 0.91% 23
2021
Q1 		$1.5M Buy
19,961
+1,576
+9% +$115K 0.9% 21
2020
Q4 		$1.26M Sell
18,385
-28
-0.2% -$1.82K 0.9% 26
2020
Q3 		$1.07M Buy
18,413
+796
+5% +$49.5K 1.09% 21
2020
Q2 		$1.15M Buy
17,617
+3,582
+26% +$226K 1.26% 19
2020
Q1 		$833K Buy
+14,035
New +$937K 1.18% 20

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Matrix Private Capital Group's CVS Position: Q1 2026 in Review

Matrix Private Capital Group reduced its CVS Health (CVS) stake by 2.1% in Q1 2026, selling an estimated $6.39K and leaving 3,897 shares worth $280K. The position accounts for 0.13% of the portfolio, ranked #80.

Matrix Private Capital Group first reported a position in CVS in Q1 2020 and has held it in 25 quarters since. The position peaked at $2M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Matrix Private Capital Group held 3,897 shares of CVS Health worth $280K as of Q1 2026.
  • Matrix Private Capital Group sold 83 CVS Health shares in Q1 2026, an estimated $6.39K.
  • CVS Health made up 0.13% of Matrix Private Capital Group's portfolio in Q1 2026, its #80 holding.
  • Matrix Private Capital Group first reported a position in CVS Health in Q1 2020 and has held it in 25 quarters since.
  • Matrix Private Capital Group's CVS Health position peaked at $2M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Matrix Private Capital Group's 13F filing for Q1 2026, filed 15 May 2026.